Syridex Bio aims to accelerate global health equity by financing the development of drugs and treatments for diseases that disproportionately affect underserved communities. They believe that by focusing on these disparities, they can make a positive impact on people's health while also generating strong financial returns for their investors. Despite the slow progress in addressing these inequities, Syridex Bio is committed to bridging the gap in the market and ensuring that everyone has the opportunity to live a healthy life.